Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02117310 · ClinicalTrials.gov registry record · NA

ICG Use in Angiography for Nasoseptal Flap Harvest

A NA study, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
5
Enrollment target

NCT02117310: Completed NA study, sponsored by Ohio State University.

NCT02117310 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02117310, a NA study, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
5 participants
Enrollment target

Study Summary

This is a feasibility study in which indocyanine green (ICG) will be administered during routine expanded endonasal approach (EEA) for cranial base pathologies in which a nasoseptal flap harvest will be necessary. The research entails administering ICG, which is already widely used during open neurosurgical procedures, to identify the blood supply at two distinct stages of endonasal cranial base surgery: during nasoseptal flap harvest and after final positioning of the nasoseptal flap to ensure its viability before ending the case.

Primary Outcome

The researcher will administer ICG, which is already widely used during open neurosurgical procedures, to identify the blood supply at two distinct stages of endonasal cranial base surgery: during nasoseptal flap harvest and after final positioning of the nasoseptal flap to ensure its viability before ending the case. This study will determine feasibility of other larger clinical trials using this method.

Interventions

  • DRUG indocyanine green

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2015-03
Est. Completion 2015-11
Phase NA
Ohio State University

552 total trials

What the finished NCT02117310 record still lists

NCT02117310 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which indocyanine green is the first listed.

NCT02117310 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02117310 about?

NCT02117310 is a clinical study titled "ICG Use in Angiography for Nasoseptal Flap Harvest". This is a feasibility study in which indocyanine green (ICG) will be administered during routine expanded endonasal approach (EEA) for cranial base pathologies in which a nasoseptal flap harvest will be necessary. The research entails administering ICG, which is already widely used during open neuro...

What is the current status of trial NCT02117310?

This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2015-03. Estimated completion is 2015-11.

What interventions are being tested in trial NCT02117310?

The interventions under investigation include: indocyanine green (DRUG).

Who is sponsoring clinical trial NCT02117310?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02117310's enrollment target sits among peer trials

5 1988th of 2000 higher than 5 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02117310, the US trial registry maintained by the National Library of Medicine. NCT02117310 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.